| scholarly article | Q13442814 |
| P50 | author | Patrick C D'Haese | Q100735120 |
| Isabel R. Orriss | Q51846832 | ||
| Dongxing Zhu | Q56565453 | ||
| Vicky MacRae | Q61727672 | ||
| P2093 | author name string | Timothy R Arnett | |
| Caroline P D Wheeler-Jones | |||
| José L Millán | |||
| Britt Opdebeeck | |||
| Jessal J Patel | |||
| Lucie E Bourne | |||
| P2860 | cites work | Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects | Q72898743 |
| Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies | Q73221508 | ||
| Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice | Q78208136 | ||
| Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification | Q85008910 | ||
| Effects of extracellular nucleotides on single cells and populations of human osteoblasts: contribution of cell heterogeneity to relative potencies | Q41963594 | ||
| miRNA-221 and miRNA-222 synergistically function to promote vascular calcification. | Q42084206 | ||
| Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels | Q42129293 | ||
| Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1(-/-) mice. | Q42272777 | ||
| Activation of the P2Y2 receptor regulates bone cell function by enhancing ATP release. | Q42508641 | ||
| Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression | Q43843547 | ||
| Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women | Q44503709 | ||
| Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate | Q46279735 | ||
| P2X7-induced zeiosis promotes osteogenic differentiation and mineralization of postmenopausal bone marrow-derived mesenchymal stem cells | Q46283654 | ||
| Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling | Q46287351 | ||
| The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors. | Q46290472 | ||
| Mechanism of calcification: inhibitory role of pyrophosphate | Q46291732 | ||
| Rat osteoblast cultures | Q46292216 | ||
| Prevention of vascular calcification by polyphosphates and nucleotides- role of ATP. | Q46299267 | ||
| The P2Y2 nucleotide receptor is an inhibitor of vascular calcification. | Q49751552 | ||
| Osteoblast responses to nucleotides increase during differentiation. | Q52020613 | ||
| ATP acts as a survival signal and prevents the mineralization of aortic valve. | Q54527062 | ||
| PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification | Q24290745 | ||
| P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid | Q28512950 | ||
| ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling | Q28573347 | ||
| Acidosis is a key regulator of osteoblast ecto-nucleotidase pyrophosphatase/phosphodiesterase 1 (NPP1) expression and activity | Q33288810 | ||
| Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification | Q33291152 | ||
| Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia | Q33727722 | ||
| The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells | Q33911294 | ||
| Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice | Q34168605 | ||
| The roles of P2Y2 purinergic receptors in osteoblasts and mechanotransduction | Q34277217 | ||
| Optimisation of the differing conditions required for bone formation in vitro by primary osteoblasts from mice and rats | Q34350355 | ||
| Generation of rodent and human osteoblasts. | Q34502177 | ||
| Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation. | Q34852675 | ||
| Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. | Q35083898 | ||
| Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle | Q35087040 | ||
| Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification | Q35525230 | ||
| Mechanisms and clinical consequences of vascular calcification | Q36142207 | ||
| Hypophosphatasia and the Extracellular Metabolism of Inorganic Pyrophosphate: Clinical and Laboratory Aspects: Part I | Q36396245 | ||
| The vascular biology of calcification. | Q36764999 | ||
| Physiology and pathophysiology of purinergic neurotransmission | Q36788894 | ||
| Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. | Q37162394 | ||
| Purinergic signalling in the musculoskeletal system. | Q37468714 | ||
| Purinergic signalling in osteoblasts. | Q37971510 | ||
| Calcium regulation of vascular smooth muscle cell-derived matrix vesicles. | Q38035617 | ||
| ATP and arterial calcification | Q38080569 | ||
| Purinergic signaling and blood vessels in health and disease. | Q38171010 | ||
| The role of purinergic signalling in the musculoskeletal system | Q38483890 | ||
| Mesenchymal Stem Cells Ageing: Targeting the "Purinome" to Promote Osteogenic Differentiation and Bone Repair | Q38692744 | ||
| Pyrophosphate: a key inhibitor of mineralisation. | Q38803194 | ||
| Is there a basis for distinguishing two types of P2-purinoceptor? | Q39497248 | ||
| Purinoceptors: are there families of P2X and P2Y purinoceptors? | Q40510363 | ||
| P2 receptor expression profiles in human vascular smooth muscle and endothelial cells | Q40619432 | ||
| Calcification of rachitic rat cartilage in vitro by extracellular matrix vesicles | Q41878209 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 3230-3243 | |
| P577 | publication date | 2017-10-04 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | Inhibition of arterial medial calcification and bone mineralization by extracellular nucleotides: The same functional effect mediated by different cellular mechanisms | |
| P478 | volume | 233 |
| Q90029208 | Differing calcification processes in cultured vascular smooth muscle cells and osteoblasts |
| Q90058346 | Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model |
| Q92139684 | Inhibition of vascular smooth muscle cell calcification by ATP analogues |
| Q61443088 | Suppression of SIRT1 in Diabetic Conditions Induces Osteogenic Differentiation of Human Vascular Smooth Muscle Cells via RUNX2 Signalling |
Search more.